Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04848727
Other study ID # DePIct
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 6, 2021
Est. completion date June 7, 2022

Study information

Verified date November 2022
Source Sharp HealthCare
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To validate the benefits of recognizing asymmetric lung disease like atelectasis and pneumothorax in neonatal respiratory distress syndrome using electrical impedance tomography


Description:

To quantify the changes in regional lung air content associated with the variations of the respiratory support settings, the following approach will be used. The changes in local air content will be determined in the selected EIT region of interest (ROI) in terms of a change in local average lung density and relative impedance change with respect to a reference air content. - TimePeriod 1 (t1): The reference lung air content will be measured once the asymmetric lung disease is identified on chest x-ray. - TimePeriod 2 (t2): A post-lung disease EIT measurement will be obtained at 6-24 hours later or immediately after therapy (i.e. chest tube placement or needle decompression). Eligible infants with confirmed asymmetric lung disease (atelectasis or pneumothorax) by radiographic images requiring no respiratory support or on mechanical support or nCPAP therapy of 5-8 cm H20 achieved with a ventilator, an underwater "bubble" system, or a variable-flow device will be enrolled. All of these methods of providing the therapy are done with FDA approved devices currently used in the NICU. EIT data will be acquired using The LuMon Monitor-Neo, GUI software 1.0.x.x/TIC software 1.6.x.xxx (SenTec, Landquart, Switzerland). The EIT system will be placed at the subject's bedside to collect EIT measurements: Ventilation distribution%, changes in regional aeration in arbitrary units (AU), dependent and non-dependent silent spaces. A data acquisition cart will also be placed at the subject's bedside to collect hemodynamic and respiratory parameters measurements including: Heart rate (HR), blood pressure (BP), respiratory rate (RR), fraction of inspired oxygen (FiO2), transcutaneous carbon dioxide (TcCO2), and peripheral oxygen saturation (SpO2) via bedside monitoring devices. The LuMon belts for neonates are disposable single-patient use belts that are adhesive-free and consists of 32 electrodes which are sized to the infant's chest circumference, generally at the 4th - 6th rib. Warmed NeoContactAgent (ingredients: Aqua, Glycerol, Sodium chloride) will be applied to the belt before placing on the infant. The embedded position sensor permits the LuMon System to measure and display the patient's position. The soft and expandable closure band prevents the chest from being constrained by the belt and, consequently, prevents restrictions to breathing and increased work of breathing. EIT measurements and data will be collected on each timeperiods (t1 and t2) for approximately 15-30 minutes on invasive or non-invasive ventilatory support. The EIT measurements may be repeated on an eligible participant if a reoccurrence of a confirmed asymmetric lung disease, atelectasis or pneumothorax, is identified on a radiographic image. EIT is currently not used for patient care management at SMBHWN. EIT's use for patient care management is purely experimental. EIT, when used solely for physiologic data collection, its use is not subject to 21 CFR 50, 21 CFR 56, or 21 CFR 812. Data collection via EIT will occur when the subject is in a quiet, sleeping state, and can be accomplished in a convenient time period when care givers or parents are not interacting with the subject.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 7, 2022
Est. primary completion date June 7, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. All infants admitted to the NICU at SMBHWN 2. Informed consent obtained 3. Atelectasis confirmed on CXR 4. Pneumothorax confirmed on CXR Exclusion Criteria: 1. Declined consent 2. Infants with known congenital anomalies

Study Design


Intervention

Other:
Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT)
The EIT system will be placed at the subject's bedside to collect EIT measurements: Ventilation distribution%, changes in regional aeration in arbitrary units (AU), dependent and non-dependent silent spaces. A data acquisition cart will also be placed at the subject's bedside to collect hemodynamic and respiratory parameters measurements including: Heart rate (HR), blood pressure (BP), respiratory rate (RR), fraction of inspired oxygen (FiO2), transcutaneous carbon dioxide (TcCO2), and peripheral oxygen saturation (SpO2) via bedside monitoring devices. The LuMon belts for neonates are disposable single-patient use belts that are adhesive-free. EIT measurements and data will be collected on each timeperiods (t1 and t2) for approximately 15-30 minutes on invasive or non-invasive ventilatory support.

Locations

Country Name City State
United States Sharp Mary Birch Hospital for Women & Newborns San Diego California

Sponsors (1)

Lead Sponsor Collaborator
Sharp HealthCare

Country where clinical trial is conducted

United States, 

References & Publications (4)

Costa EL, Borges JB, Melo A, Suarez-Sipmann F, Toufen C Jr, Bohm SH, Amato MB. Bedside estimation of recruitable alveolar collapse and hyperdistension by electrical impedance tomography. Intensive Care Med. 2009 Jun;35(6):1132-7. doi: 10.1007/s00134-009-1447-y. Epub 2009 Mar 3. — View Citation

Kallio M, Rahtu M, van Kaam AH, Bayford R, Rimensberger PC, Frerichs I. Electrical impedance tomography reveals pathophysiology of neonatal pneumothorax during NAVA. Clin Case Rep. 2020 May 24;8(8):1574-1578. doi: 10.1002/ccr3.2944. eCollection 2020 Aug. — View Citation

Miedema M, McCall KE, Perkins EJ, Sourial M, Böhm SH, Waldmann A, van Kaam AH, Tingay DG. First Real-Time Visualization of a Spontaneous Pneumothorax Developing in a Preterm Lamb Using Electrical Impedance Tomography. Am J Respir Crit Care Med. 2016 Jul 1;194(1):116-8. doi: 10.1164/rccm.201602-0292LE. — View Citation

Rahtu M, Frerichs I, Waldmann AD, Strodthoff C, Becher T, Bayford R, Kallio M. Early Recognition of Pneumothorax in Neonatal Respiratory Distress Syndrome with Electrical Impedance Tomography. Am J Respir Crit Care Med. 2019 Oct 15;200(8):1060-1061. doi: 10.1164/rccm.201810-1999IM. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Compare respiratory rate Compare the respiratory rate shown on the LuMon monitor and the one shown on other devices Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Other Compare total impedance from the ventilator and the LuMon device Compare total impedance from the ventilator and the LuMon device Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Other Compare total volumes from the ventilator and the LuMon Device Compare total volumes from the ventilator and the LuMon Device Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Primary Atelectasis: Change in measured % Unventilated Lung between TimePeriods (t1 and t2) Atelectasis will be calculated using the percentage of the lung fields that are not engaged in tidal volume.(VT) Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Primary Pneumothorax: Change in measured % Unventilated Lung between TimePeriods (t1 and t2) To determine pneumothorax is the percentage of lung areas with non-negligible impedance change during breathing. Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Secondary Geometric Center of Ventilation (CoV) In the human lung the ideal non-dependent to dependent CoV is 63%. Thus a value of 55% would indicate greater ventilation in the non-dependent lung. Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Secondary Change in % of total tidal volume (VT) within 8 lung regions % of total tidal volume will be determined from the trough and peak-to-peak height of the time-volume EIT within the 8 regions of interest Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Secondary Relative change in uncalibrated aeration (end-expiratory lung volume) End-expiratory lung volume will be analyzed using four ventral to dorsal regions of interest (ROI) by EIT Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
Secondary Regional distribution of tidal volume Regional distribution of tidal volume will be analyzed using four ventral to dorsal regions of interest (ROI) by EIT Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05180955 - The Role of Clamping Before Removal of a Pneumothorax Drain Connected to a Digital Drainage System. N/A
Active, not recruiting NCT05077111 - A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia Phase 4
Recruiting NCT05230420 - Urine Bag Usage Versus Chest Drain Clamping After Lung Resection Surgeries N/A